Glucose lowering treatments and cardiovascular risk

被引:0
|
作者
Bonnet, F. [1 ]
机构
[1] Hop Sud, Serv Endocrinol Diabetol Nutr, Rennes, France
关键词
Cardiovascular; Glucose lowering treatment; Diabetes; MYOCARDIAL-INFARCTION; MORTALITY; OUTCOMES; SULFONYLUREAS; PIOGLITAZONE; DISEASE; TRIAL;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:281 / 284
页数:4
相关论文
共 50 条
  • [1] Glucose Lowering, Hypoglycemia, and Cardiovascular Disease Risk
    Reboldi G.
    Gentile G.
    Angeli F.
    Mazzotta G.
    Martire P.
    Garofoli M.
    Verdecchia P.
    Current Cardiovascular Risk Reports, 2010, 4 (2) : 159 - 164
  • [2] Intensive glucose lowering to reduce cardiovascular risk: contra
    Marx, N.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (20) : 1061 - 1061
  • [3] Lowering blood glucose therapeutic strategies and cardiovascular risk
    Charpentier, G.
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2010, 14 (09): : 298 - 303
  • [4] Intensive glucose lowering to reduce cardiovascular risk: pro
    Martin, S.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2009, 134 (20) : 1060 - 1060
  • [5] New Treatments for Type 2 Diabetes: Cardiovascular Protection Beyond Glucose Lowering?
    Jayawardene, Dilshani
    Ward, Glenn M.
    O'Neal, David N.
    Theverkalam, Geetha
    MacIsaac, Andrew I.
    MacIsaac, Richard J.
    HEART LUNG AND CIRCULATION, 2014, 23 (11): : 997 - 1008
  • [6] Intensive Glucose Lowering in Cardiovascular Risk Management - Unsolved Questions
    Shimabukuro, Michio
    Masuzaki, Hiroaki
    Sara, Masataka
    CIRCULATION JOURNAL, 2012, 76 (03) : 593 - 595
  • [7] Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
    Hertzel C. Gerstein
    Nature Reviews Endocrinology, 2009, 5 : 270 - 275
  • [8] Is it possible to reduce cardiovascular risk with glucose-lowering approaches?
    Gerstein, Hertzel C.
    NATURE REVIEWS ENDOCRINOLOGY, 2009, 5 (05) : 270 - 275
  • [9] Intensive Glucose Lowering and Cardiovascular Outcomes
    Fan, Ye
    Zhang, An-Mei
    Xiao, Ying-Bin
    NEW ENGLAND JOURNAL OF MEDICINE, 2011, 364 (23): : 2263 - 2264
  • [10] Lipid Effects and Cardiovascular Disease Risk Associated with Glucose-Lowering Medications
    Barbara E. Stähli
    Catherine Gebhard
    Jean-Claude Tardif
    Current Cardiology Reports, 2015, 17